Why ZEJULA?
ZEJULA is a once-daily oral maintenance treatment for women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, after the cancer has completely or partially responded to the most recent chemotherapy.1
ZEJULA Results
Look into the clinical trial data to learn about the effect of ZEJULA on women with recurrent ovarian cancer.
Is ZEJULA Right for You?
Find out if ZEJULA can help you with your recurrent ovarian, fallopian tube, or primary peritoneal cancer.
Taking ZEJULA
Get details on ZEJULA dosing and handling, as well as information about how your doctor will monitor your treatment.
Reference: 1. ZEJULA (niraparib) Prescribing Information. GlaxoSmithKline; 2020.
Back to Top